Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2025	Oct. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss, including amounts attributable to noncontrolling interest	$ (55,051)	$ (15,434)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense, net of amounts capitalized	161,793	139,263
Change in fair value of acquisition related contingent consideration	0	3,750
Charitable donation of common stock	5,496	8,871
Amortization of intangible assets	6,050	5,931
Depreciation expense	2,184	2,361
Amortization of deferred contract acquisition costs	40,747	35,650
Net amortization of premiums or discounts on short-term investments	(7,346)	(12,933)
Unrealized foreign exchange loss (gain), net	13,386	(5,443)
Other non-cash expense, net	631	768
Changes in assets and liabilities:
Accounts receivable	46,315	(31,658)
Prepaid expenses and other current assets	(4,290)	2,497
Deferred contract acquisition costs	(36,328)	(35,706)
Other non-current assets	414	851
Accounts payable	812	33
Accrued expenses and other current liabilities	1,862	(240,614)
Accrued compensation and benefits	(7,895)	(8,815)
Deferred revenue	17,500	34,503
Other non-current liabilities	819	(11,068)
Net cash provided by (used in) operating activities	187,099	(127,193)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term investments	(798,283)	(503,394)
Proceeds from maturities of short-term investments	589,527	524,862
Proceeds from sales of short-term investments	1,367	0
Additions to property and equipment	(6,854)	(2,608)
Payments for business combination, net of cash acquired	0	(20,210)
Payments for asset acquisition	0	(7,660)
Other investing activities	0	457
Net cash used in investing activities	(214,243)	(8,553)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	15,457	17,895
Issuance of common stock under employee stock purchase plan	8,404	7,932
Payments for taxes related to net share settlement of equity awards	(529)	0
Settlement of acquisition related contingent cash consideration	0	(4,900)
Net cash provided by financing activities	23,332	20,927
Impact of foreign exchange on cash and cash equivalents	394	3,455
Net decrease in cash and cash equivalents	(3,418)	(111,364)
Cash and cash equivalents at beginning of period	227,649	287,996
Cash and cash equivalents at end of period	224,231	176,632
Supplemental disclosure of cash flow information:
Cash paid (refunds) for income taxes related to the bilateral advance pricing agreement	(2,451)	187,735
Other cash paid for income taxes	1,157	2,585
Supplemental disclosure of non-cash investing and financing activities:
Unpaid property and equipment in accounts payable and accrued expenses	990	377
Stock-based compensation capitalized as internal-use software cost	$ 367	$ 0